FDA Compliance for Peptide Therapy and BPC 157 Holt Law RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicals The Peptide Split: How GLP 1s, Lutathera, Vosoritide, and Peptide Cancer Vaccines Are Quietly Rewriting Medicine While BPC 157, TB 500, MOTS c, and the Wellness Grift Borrow Their Halo In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few FDA Moves to Reevaluate Several Peptides American Med Spa Association